Preventable drug related morbidity (PDRM) and its causes: a critical review of current concepts

Tobias Dreischulte, Julienne Johnson

Research output: Contribution to journalConference Contribution

Abstract

Abstract of a paper from the ESCP 40th International Symposium on Clinical Pharmacy.Clinical Pharmacy: Connecting Care and Outcomes Dublin
Ireland, 19–21 October 2011. The problem of preventable drug related morbidity (PDRM) is an area of increasing concern internationally. The pharmaco-epidemiological literature mainly reports preventable adverse drug events (pADEs) and medication errors as their causes, while the pharmaceutical care literature focuses on reporting the identification
and/or resolution of drug therapy problems and related concepts.

Fingerprint

Morbidity
Medication Errors
Pharmaceutical Services
Drug-Related Side Effects and Adverse Reactions
Pharmaceutical Preparations
Drug therapy
Drug Therapy

Keywords

  • drug related morbidity
  • drug therapy

Cite this

@article{19ed20686aa44a0d887d6df881e53c49,
title = "Preventable drug related morbidity (PDRM) and its causes: a critical review of current concepts",
abstract = "Abstract of a paper from the ESCP 40th International Symposium on Clinical Pharmacy.Clinical Pharmacy: Connecting Care and Outcomes DublinIreland, 19–21 October 2011. The problem of preventable drug related morbidity (PDRM) is an area of increasing concern internationally. The pharmaco-epidemiological literature mainly reports preventable adverse drug events (pADEs) and medication errors as their causes, while the pharmaceutical care literature focuses on reporting the identificationand/or resolution of drug therapy problems and related concepts.",
keywords = "drug related morbidity, drug therapy",
author = "Tobias Dreischulte and Julienne Johnson",
year = "2012",
month = "2",
doi = "10.1007/s11096-011-9602-2",
language = "English",
volume = "34",
pages = "192--192",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7711",
number = "1",

}

Preventable drug related morbidity (PDRM) and its causes: a critical review of current concepts. / Dreischulte, Tobias; Johnson, Julienne.

In: International Journal of Clinical Pharmacy, Vol. 34, No. 1, 02.2012, p. 192-192.

Research output: Contribution to journalConference Contribution

TY - JOUR

T1 - Preventable drug related morbidity (PDRM) and its causes: a critical review of current concepts

AU - Dreischulte, Tobias

AU - Johnson, Julienne

PY - 2012/2

Y1 - 2012/2

N2 - Abstract of a paper from the ESCP 40th International Symposium on Clinical Pharmacy.Clinical Pharmacy: Connecting Care and Outcomes DublinIreland, 19–21 October 2011. The problem of preventable drug related morbidity (PDRM) is an area of increasing concern internationally. The pharmaco-epidemiological literature mainly reports preventable adverse drug events (pADEs) and medication errors as their causes, while the pharmaceutical care literature focuses on reporting the identificationand/or resolution of drug therapy problems and related concepts.

AB - Abstract of a paper from the ESCP 40th International Symposium on Clinical Pharmacy.Clinical Pharmacy: Connecting Care and Outcomes DublinIreland, 19–21 October 2011. The problem of preventable drug related morbidity (PDRM) is an area of increasing concern internationally. The pharmaco-epidemiological literature mainly reports preventable adverse drug events (pADEs) and medication errors as their causes, while the pharmaceutical care literature focuses on reporting the identificationand/or resolution of drug therapy problems and related concepts.

KW - drug related morbidity

KW - drug therapy

U2 - 10.1007/s11096-011-9602-2

DO - 10.1007/s11096-011-9602-2

M3 - Conference Contribution

VL - 34

SP - 192

EP - 192

JO - International Journal of Clinical Pharmacy

T2 - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7711

IS - 1

ER -